Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Completed

Conditions studied: Bladder Cancer

In brief

The goal of this research study is to improve detection of cancer outside of the bladder through genetic testing and improved imaging.

Key facts

Study ID

NCT02203136

Run by

M.D. Anderson Cancer Center

People needed

16

Starts

2014-06-25

Expected to finish

2019-05-16

Last updated by the study team

2019-05-22

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with biopsy proven bladder cancer of any age will be eligible for enrollment.

You may not qualify if…

• Contraindication to pelvic MRI (metallic implants/hardware, claustrophobia)
• Participants who have previously received chemotherapy as part of multimodal therapy.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.